Teligent
TLGT
#10190
Rank
A$22.72 M
Marketcap
A$0.24
Share price
-13.85%
Change (1 day)
1,428.27%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -A$58.52 Million

According to Teligent's latest financial reports the company's current earnings are A$46.29 Million. In 2020 the company made an earning of -A$54.2 Million a decrease over its 2019 earnings that were of -A$11.32 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$58.52 Million7.97%
2020-A$54.2 Million378.89%
2019-A$11.32 Million-46.87%
2018-A$21.31 Million10.47%
2017-A$19.29 Million-637.49%
2016A$3.58 M-179.64%
2015-A$4.51 Million-181.72%
2014A$5.51 M-4806.02%
2013-A$0.12 Million-97.35%
2012-A$4.43 Million6.23%
2011-A$4.17 Million-18.59%
2010-A$5.12 Million-11.37%
2009-A$5.78 Million98.4%
2008-A$2.91 Million156.15%
2007-A$1.14 Million-59.36%
2006-A$2.8 Million17.92%
2005-A$2.38 Million37.7%
2004-A$1.73 Million25.51%
2003-A$1.38 Million-289.84%
2002A$0.72 M-1605.88%
2001-A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.63 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA